Translumina Therapeutics Llp, a converted and dissolved limited liability partnership, was established on 01 December 2009 in New Delhi, Delhi, India. Engaging in medical & laboratory equipment within the healthcare sector, it holds LLPIN: AAA-0435. Registered under ROC Roc Delhi. It has total obligation of contribution of ₹0.10 M.
Employing 363 professional, Its leadership includes Vishal Sharma (Designated Partner), Indranil Mukherjee (Designated Partner), Gurmit Singh Chugh (Partner). Past directors included Gurmit Singh Chugh, Avnish Mehra. It holds ₹60.95 Cr open charges and ₹9.25 Cr settled loans. Its latest date of accounts and solvency statement 31 March 2024. It is based at Ground Floor, Metro Tower Lsc,Mor Land, New Rajinder Nagar, New Delhi, Delhi, 110060.
AAA-0435
01 December 2009
₹0.10 M
Roc Delhi
Converted And Dissolved
Explore comprehensive insights into Translumina Therapeutics Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vishal Sharma | Designated Partner | 11 Mar 2020 | Current |
| Indranil Mukherjee | Designated Partner | 15 Mar 2024 | Current |
| Gurmit Singh Chugh | Partner | 17 May 2019 | Current |
| Avnish Mehra | Partner | 11 Mar 2020 | Current |
| Punita Sharma | Designated Partner | 01 Dec 2009 | Current |
| Vishal Omprakash Goenka | Designated Partner | 15 Mar 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Designated Partner | 10 May 2019 | Past |
| Pramod Abcsdd | Designated Partner | 10 Mar 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Translumina Therapeutics Llp, for the financial year ended 2021, experienced significant reduction in revenue, with a 11.84% decrease. The company also saw a substantial fall in profitability, with a 36.98% decrease in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
Unlock access to Translumina Therapeutics Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹609,503,560.00
₹92,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Nov 2022 | Hdfc Bank Limited | ₹2.30 M | Open |
| 30 Aug 2022 | Icici Bank Limited | ₹10.00 Cr | Open |
| 20 Apr 2022 | Hdfc Bank Limited | ₹1.61 M | Open |
| 28 Jan 2022 | Hdfc Bank Limited | ₹50.00 Cr | Open |
| 27 Nov 2021 | Hdfc Bank Limited | ₹0.80 M | Open |
Explore comprehensive loan charge details -
Translumina Therapeutics Llp has a workforce of 363 employees as of Feb 08, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Translumina Therapeutics Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Translumina Therapeutics Llp's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Translumina Therapeutics Llp last Annual general meeting of members was held on 31 Mar 2024 as per latest MCA records. was completed.
Progress on Translumina Therapeutics Llp has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
Progress on Indranil Mukherjee was appointed as a Designated Partner was appointed as a Designated Partner on 15 Mar 2024 & has been associated with this company since 1 year 8 months . was documented.
The activity Vishal Omprakash Goenka was appointed as a Designated Partner was appointed as a Designated Partner on 15 Mar 2024 & has been associated with this company since 1 year 8 months . was completed.
The activity A charge with Hdfc Bank Limited of Rs. 500.00 M registered on 28 Jan 2022 with Charge ID 100534152 was modified on 21 Mar 2023. was completed.
A charge with Hdfc Bank Limited amounted to Rs. 2.30 M with Charge ID 100654416 was registered on 18 Nov 2022. was recorded as a recent event.
/PRNewswire/ -- Translumina, a global leader in Interventional Cardiovascular medical devices with manufacturing presence in Germany and India, today announced....
The LLPIN of Translumina Therapeutics Llp is AAA-0435.
Translumina Therapeutics Llp is headquartered at Ground Floor, Metro Tower Lsc,Mor Land, New Rajinder Nagar, New Delhi, Delhi, 110060.
Translumina Therapeutics Llp was incorporated on 01 December 2009.
The current directors of Translumina Therapeutics Llp are
The primary industry of Translumina Therapeutics Llp is Healthcare.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX